Total investments received (USD): 286m
Round value (USD): 105m
Round investors:
Bpifrance
Jeito Capital
Novo A/S
Pureos Bioventures
RA Capital Management
Schroders
Company: Alentis Therapeutics






Belgium
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain